Superpulsed CO2 laser with intraoperative pathologic assessment for treatment of periorbital basal cell carcinoma involving eyelash line

Treatment periorbital basal cell carcinoma by co2 laser

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201404036403N4

Enrollment

Registered

2014-04-18

Start date

2010-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

basal cell carcinoma. Malignant neoplasms

Interventions

Use of combination of curettage and 3 pass of CO2 laser with 16-20 watt and 500-700 microsecond.

Treatment - Devices

Use of combination of curettage and 3 pass of CO2 laser with 16-20 watt and 500-700 microsecond

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria included: lesions with a diameter larger than 2 cm, pregnancy, patients younger than 30 years old, recurrence after excision, wide extension to conjunctiva, morpheoic form, immunosuppression, keloid former and any orbital contraindication for laser therapy. Inclusion criteria included: Pathologically ducumented basal cell carcinoma involving eyelash line

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pathologic assesment. Timepoint: monthly in first year and 3 month thereafter. Method of measurement: Clinical and pathologic observation.	—

Secondary

Measure	Time frame
Healing. Timepoint: monthly in first year and 3 month thereafter. Method of measurement: Clinical and pathologic observation.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026